{"mainPropery":{"diseaseId":12562,"diseaseName":"Mucopolysaccharidosis type IV","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12562/mucopolysaccharidosis-type-iv","synonyms":["MPS4","MPSIV","Mucopolysaccharidosis type 4","Morquio disease"],"synonyms-with-source":[{"name":"MPS4","source":"OrphaData.Org"},{"name":"MPSIV","source":"OrphaData.Org"},{"name":"Mucopolysaccharidosis type 4","source":"OrphaData.Org"},{"name":"Morquio disease","source":"Orphanet, NORD"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"582"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""}],"resource descriptions":[{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/mucopolysaccharidosis-type-iv' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Mucopolysaccharidosis type IV. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/morquio-syndrome/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='https://medlineplus.gov/ency/article/001206.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Mucopolysaccharidoses-Fact-Sheet#3195_4' target='_blank'>National Institute of Neurological Disorders and Stroke (NINDS)</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/947254-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=582' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:12804' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2158,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"<a href='https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has Disease-Specific Assistance Programs designed to help patients with out-of-pocket costs such as monthly insurance premiums or deductibles. In addition, some programs may provide financial assistance for additional expenses related to a patient's diagnosis such as travel to see a specialist.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":12073,"questionText":"What is mucopolysaccharidosis type IV?","answerText":"<strong>Mucopolysaccharidosis type IV (MPS IV)</strong>, also known as Morquio syndrome, is a rare metabolic condition in which the body is unable to break down long chains of sugar molecules called glycosaminoglycans. As a result, toxic levels of these sugars accumulate in cell structures called lysosomes, leading to the various signs and symptoms associated with the condition. Affected people generally develop features of MPS IV between the ages of 1 and 3. These signs and symptoms may include abnormalities of the skeleton, eyes, heart and respiratory system. There are two forms of MPS IV:\r\n<ul>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/3785/mucopolysaccharidosis-type-iva\" target=\"_blank\">MPS IVA</a> is caused by changes (mutations) in the <a href=\"https://ghr.nlm.nih.gov/gene/GALNS\" target=\"_blank\"><em>GALNS</em></a> gene.</li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/diseases/3786/morquio-syndrome-b\" target=\"_blank\">MPS IVB</a> is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\">GLB1</a></em> gene.</li>\r\n</ul>\r\nBoth forms are inherited in an autosomal recessive manner. Treatment is based on the signs and symptoms present in each person.[13623][13629][13650]","dateModified":"2017-07-30T14:40:00"},"basicQuestions":[{"questionId":12046,"questionText":"What are the signs and symptoms of mucopolysaccharidosis type IV?","answerText":"People affected by mucopolysaccharidosis type IV (MPS IV) often develop signs and symptoms of the condition in early childhood. The condition is considered progressive; however, the rate at which symptoms worsen varies significantly among affected people. All people affected by MPS IV develop skeletal problems such as <a href=\"https://medlineplus.gov/ency/article/001241.htm\" target=\"_blank\">scoliosis</a>, knock-knees, short stature, <a href=\"https://medlineplus.gov/ency/article/003321.htm\" target=\"_blank\">pectus carinatum</a> and variety of other abnormalities of the ribs, chest, spine, hips, and wrists.[13623][13624] Another common feature of MPS IV is an underdeveloped odontoid process (a peg-like bone in the neck that helps stabilize the <a href=\"https://medlineplus.gov/ency/imagepages/9535.htm\" target=\"_blank\">cervical vertebrae</a>). This can misalign, compress and damage the spinal cord, leading to paralysis or even death.[13623]<br />\r\n<br />\r\nOther features of the condition include:[13623][13625]<br />\r\n<ul>\r\n    <li>Coarse facial features</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003295.htm\" target=\"_blank\">Hypermobile joints</a></li>\r\n    <li>Corneal clouding and vision loss</li>\r\n    <li>Heart valve abnormalities</li>\r\n    <li>Respiratory complications, including airway obstruction, sleep apnea and restrictive lung disease</li>\r\n    <li>Widely-spaced, discolored teeth with thin enamel</li>\r\n    <li>Mild to moderate hearing loss</li>\r\n    <li>Mild <a href=\"https://medlineplus.gov/ency/article/003275.htm\" target=\"_blank\">hepatomegaly</a></li>\r\n</ul>\r\n<br />","dateModified":"2017-07-23T22:35:00","resourceClassificationName":"Symptoms","references":[{"referenceId":13623,"authors":"Debra S Regier, MD, PhD, Matthew Oetgen, MD, and Pranoot Tanpaiboon, MD","articleTitle":"Mucopolysaccharidosis Type IVA","bookWebsiteJournalTitle":"GeneReviews","date":"March 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK148668","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13624,"authors":"Di Cesare A, Di Cagno A, Moffa S, Teresa P, Luca I, Giombini A","articleTitle":"A description of skeletal manifestation in adult case of morquio syndrome: radiographic and MRI appearance","bookWebsiteJournalTitle":"Case Rep Med","date":"2012","volume":"2012","pages":"324596","url":"","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13625,"authors":"Robert Wynn, MD, MRCP, FRCPath","articleTitle":"Mucopolysaccharidoses: Clinical features and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"June 2017","volume":"","pages":"","url":"","dateAccessed":"2017-07-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12047,"questionText":"What causes mucopolysaccharidosis type IV?","answerText":"There are two forms of mucopolysaccharidosis type IV (MPS IV): <a href=\"https://rarediseases.info.nih.gov/diseases/3785/mucopolysaccharidosis-type-iva\" target=\"_blank\">type A</a> and <a href=\"https://rarediseases.info.nih.gov/diseases/3786/morquio-syndrome-b\" target=\"_blank\">type B</a>. Type A is caused by changes (mutations) in&nbsp;the <em><a href=\"https://ghr.nlm.nih.gov/gene/GALNS\" target=\"_blank\">GALNS</a></em> gene and type B is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\">GLB1</a></em> gene. Both of these genes encode enzymes that help the body breakdown large sugar molecules called glycosaminoglycans (GAGs).&nbsp;If mutations reduce or eliminate the amount of these enzymes functioning in the body, GAGs accumulate in specialized cell structures called lysosomes (compartments in the cell that break down and recycle different types of molecules). This buildup of GAGs is toxic to various tissues in the body and leads to the signs and symptoms associated&nbsp;with the condition.[13628][13629]","dateModified":"2017-07-24T15:51:00","resourceClassificationName":"Cause","references":[{"referenceId":13628,"authors":"","articleTitle":"Mucopolysaccharidosis type IV","bookWebsiteJournalTitle":"Genetics Home Reference","date":"July 2010","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/mucopolysaccharidosis-type-iv","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13629,"authors":"Kazuki Sawamoto, PhD, MS","articleTitle":"Morquio Syndrome (Mucopolysaccharidosis Type IV)","bookWebsiteJournalTitle":"Medscape Reference","date":"July 2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/947254-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12055,"questionText":"Is mucopolysaccharidosis type IV inherited?","answerText":"<p><strong></strong> Mucopolysaccharidosis type IV is inherited in an autosomal recessive manner.[13623] This means that to be affected, a person must have a mutation in both copies of the responsible gene in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n</p>\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected\r\n    </li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent\r\n    </li>\r\n    <li>25% chance to be unaffected and not be a carrier</li>\r\n</ul>","dateModified":"2017-07-25T15:13:00","resourceClassificationName":"Inheritance","references":[{"referenceId":13623,"authors":"Debra S Regier, MD, PhD, Matthew Oetgen, MD, and Pranoot Tanpaiboon, MD","articleTitle":"Mucopolysaccharidosis Type IVA","bookWebsiteJournalTitle":"GeneReviews","date":"March 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK148668","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12056,"questionText":"How is mucopolysaccharidosis type IV diagnosed?","answerText":"A diagnosis of mucopolysaccharidosis type IV is often suspected based on the presence of characteristic signs and symptoms. Additional testing can then be ordered to confirm the diagnosis, determine the severity of the condition and rule out other conditions that can be associated with similar features. These tests may include:[13623][13650]<br />\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003337.htm\" target=\"_blank\">X-rays</a></li>\r\n    <li>Specialized urine and blood tests</li>\r\n    <li>Eye exam</li>\r\n    <li>Skin fibroblast culture</li>\r\n    <li>Genetic testing to identify mutations in the <a href=\"https://ghr.nlm.nih.gov/gene/GALNS\" target=\"_blank\"><em>GALNS</em></a> or <em><a href=\"https://ghr.nlm.nih.gov/gene/GLB1\" target=\"_blank\">GLB1</a></em> genes</li>\r\n</ul>","dateModified":"2017-07-28T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13623,"authors":"Debra S Regier, MD, PhD, Matthew Oetgen, MD, and Pranoot Tanpaiboon, MD","articleTitle":"Mucopolysaccharidosis Type IVA","bookWebsiteJournalTitle":"GeneReviews","date":"March 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK148668","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13650,"authors":"","articleTitle":"Mucopolysaccharidosis IV","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2016","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/morquio-syndrome/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":3786,"relatedDiseaseName":"Morquio syndrome B","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7065,"relatedDiseaseName":"Mucopolysaccharidosis","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3785,"relatedDiseaseName":"Mucopolysaccharidosis type IVA","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3469,"phenoTypeName":"Abnormality of epiphysis morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10271,"phenoTypeName":"Abnormality of the metaphysis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14124,"phenoTypeName":"Abnormality of the ribs","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14402,"phenoTypeName":"Corneal opacity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10703,"phenoTypeName":"Delayed skeletal maturation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7947,"phenoTypeName":"Genu valgum","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15092,"phenoTypeName":"Joint hyperflexibility","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1363,"phenoTypeName":"Mucopolysacchariduria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14140,"phenoTypeName":"Pectus carinatum","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10304,"phenoTypeName":"Reduced bone mineral density","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10472,"phenoTypeName":"Short neck","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13169,"phenoTypeName":"Short thorax","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8980,"phenoTypeName":"Abnormal heart valve morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10462,"phenoTypeName":"Anteverted nares","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10149,"phenoTypeName":"Carious teeth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13297,"phenoTypeName":"Coxa valga","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12615,"phenoTypeName":"Grayish enamel","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1860,"phenoTypeName":"Hernia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10993,"phenoTypeName":"Hyperlordosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5673,"phenoTypeName":"Joint dislocation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10254,"phenoTypeName":"Platyspondyly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5601,"phenoTypeName":"Spinal canal stenosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9750,"phenoTypeName":"Wide mouth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Mucopolysaccharidosis_type_IV"}